formaldehyde has been researched along with ketorolac in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malmberg, AB; Yaksh, TL | 1 |
| Jain, NK; Kulkarni, SK; Padi, SS; Singh, S | 1 |
| Camu, F; Lebrun, P; Shi, L; Zizi, M | 1 |
| Granados-Soto, V; Medina-Santillán, R; Reyes-García, G; Rocha-González, HI | 1 |
| Lee, IO; Seo, Y | 1 |
| Aguilar-Mariscal, H; Bermúdez-Ocaña, DY; Blé-Castillo, JL; Díaz-Zagoya, JC; Flores-Murrieta, FJ; Frías, TR; Granados-Soto, V; Juárez-Rojop, IE | 1 |
| Comai, S; Domínguez-López, S; Gobbi, G; Granados-Soto, V; López-Canul, M | 1 |
| Alonso-Castro, Á; Barreras-Espinoza, I; Bologna-Molina, R; Granados-Soto, V; Isiordia-Espinoza, MA; Serafín-Higuera, N; Soto-Zambrano, JA; Zapata-Morales, R | 1 |
8 other study(ies) available for formaldehyde and ketorolac
| Article | Year |
|---|---|
Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Agonists; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Drug Combinations; Drug Interactions; Formaldehyde; Ketorolac; Male; Morphine; Motor Activity; Nociceptors; Phenylisopropyladenosine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tolmetin | 1993 |
Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
Topics: Acetic Acid; Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Endotoxins; Female; Fever; Formaldehyde; Hindlimb; Hyperalgesia; Injections, Intravenous; Isoenzymes; Isoxazoles; Ketorolac; Male; Mice; Pain; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stomach | 2004 |
Intrathecal catheterization and solvents interfere with cortical somatosensory evoked potentials used in assessing nociception in awake rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Catheterization, Peripheral; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials, Somatosensory; Formaldehyde; Hydrogen-Ion Concentration; Ketorolac; Male; Osmotic Pressure; Pain Measurement; Rats; Rats, Wistar; Solvents; Somatosensory Cortex; Spine | 2004 |
B vitamins increase the analgesic effect of ketorolac in the formalin test in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Synergism; Female; Formaldehyde; Ketorolac; Pain Measurement; Rats; Rats, Wistar; Vitamin B Complex | 2004 |
The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Topics: Animals; Behavior, Animal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Immunohistochemistry; Injections, Spinal; Ketorolac; Male; Membrane Proteins; Pain; Pain Measurement; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2008 |
Proglumide enhances the antinociceptive effect of cyclooxygenase inhibitors in diabetic rats in the formalin test.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Drug Synergism; Formaldehyde; Ketorolac; Male; Meloxicam; Proglumide; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptors, Cholecystokinin; Thiazines; Thiazoles | 2011 |
Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
Topics: Acetamides; Acetaminophen; Analgesics; Aniline Compounds; Animals; Behavior, Animal; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Partial Agonism; Formaldehyde; Ketorolac; Male; Nociception; Nociceptive Pain; Protein Binding; Rats, Wistar; Receptor, Melatonin, MT2; Signal Transduction; Tetrahydronaphthalenes; Time Factors | 2015 |
The Antinociceptive Effect of a Tapentadol-Ketorolac Combination in a Mouse Model of Trigeminal Pain is Mediated by Opioid Receptors and ATP-Sensitive K
Topics: Analgesics; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Facial Pain; Formaldehyde; Gene Expression Regulation; Injections, Intraperitoneal; KATP Channels; Ketorolac; Mice; Phenols; Receptors, Opioid; Tapentadol | 2017 |